Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A comprehensive review synthesizing the state of mRNA cancer therapeutics across design, delivery, and clinical translation—expert framing rather than a new empirical finding.
A narrative review of preclinical literature synthesizing nanocarrier design and CRISPR delivery mechanisms, raising research directions rather than reporting original empirical evidence or clinical outcomes.
Mechanistic study in syngeneic and humanized mouse models demonstrating a novel immunological pathway; lacks efficacy data from human trials and is not powered to establish clinical benefit.
A narrative review synthesizing advances in CAR-T engineering strategies for multiple disease contexts, offering conceptual direction rather than new empirical evidence or clinical outcomes.
A narrative mini-review synthesizing biological rationale, clinical trial experience, and emerging strategies for oncofetal antigen-targeted CAR-T therapies, offering expert perspective on opportunities and limitations rather than novel empirical findings.
A narrative review article that synthesizes mechanistic understanding and preclinical applications of CRISPR/Cas9 in oncology without reporting primary empirical findings, efficacy data, or clinical outcomes.
A comprehensive narrative review synthesizing epidemiology, pathophysiology, diagnostics, and therapeutic approaches to hemophilia without presenting new primary data or meta-analytic synthesis.
International Journal of Biology and Life Sciences
This is a narrative review discussing potential applications of CRISPR/Cas9 in CAR-T engineering without presenting new empirical data, clinical trials, or quantified evidence to support the proposed approaches.